Effectiveness and safety profile of tofacitinib and baricitinib in rheumatoid arthritis patients: results from a 24-month real-life prospective study in Southern-Italy. Reumatismo [Internet]. 2022 Dec. 29 [cited 2025 May 22];74(3). Available from: https://www.reumatismo.org/reuma/article/view/1511